Latest "InformEx 2012" News Stories

20:12 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "InformEx 2012" found in our extensive news archives from over 250 global news sources.

More Information about InformEx 2012 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about InformEx 2012 for you to read. Along with our medical data and news we also list InformEx 2012 Clinical Trials, which are updated daily. BioPortfolio also has a large database of InformEx 2012 Companies for you to search.

Showing "InformEx 2012" News Articles 1–25 of 771

Monday 18th March 2019

Willamette Dental Group Wins 2019 Employee Voice Award- Chosen for Distinction in Employee Engagement

Willamette Dental Group has been recognized for its success in employee engagement for a fourth time by winning the 2019 Employee Voice Award from Quantum Workplace. As an employer, Willamette Dental Group strives to provide the freedom employees need to achieve their professional aspirations. HILLSBORO, Ore. (PRWEB) March 18, 2019 Willamette Dental Group, the largest multi-specialty group dental...

Cell culture shock – a scientist’s hunt for the perfect cocktail

Science blog Studying how cells grow naturally is at the heart of cancer research. But it often relies on an unnatural world. Like the cells in our body, cells grown in a lab are kept alive with food. In the lab, this food – called cell culture media – is the red liquid you often see in plastic Petri dishe

Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space

A recent study in Frontiers in Bioengineering and Biotechnology showed uBiome and its executives as top inventors in the microbiome industry. SAN FRANCISCO (PRWEB) March 18, 2019 uBiome, the leader in microbial genomics, has the largest patent portfolio in the microbiome industry and the third highest quality portfolio following Seres Health and Nestle, as published in Frontiers in Bioengineering...

Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

- License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration. - OliX to receive an upfront payment of 2 million euro, and eligible to receive milestones, plus royalty for the development and commercialization in's SalaryScan Survey Finds Interventional Radiologists on Top

Results from a new SalaryScan survey of compensation in medical imaging published by radiology portal TUCSON, Ariz. (PRWEB) March 18, 2019 Interventional radiologists received the highest salaries among all types of diagnostic and interventional radiologists in 2018, according to a new SalaryScan survey of compensation in medical imaging published by radiology portal

Mercy Medical Center Contracts with TransformativeMed to Simplify EHR Workflows

The CORE Value Suite of Solutions Customize EHR Workflows by Clinical Specialty and Condition TransformativeMed, the first to directly embed specialized clinical workflows into the EHR to enhance usability, efficiency and renew the joy of patient care, today announced that

Bicycle Therapeutics Appoints Pierre Legault as New Director and Board Chairman

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today the appointment of Pierre Legault, MBA, CPA, as a Director and Chairman of the Board of Directors. Mr. Legault brings to Bicycle more than 35 years of executive leadership experi...

Saturday 16th March 2019

News digest – online prostate cancer predictor, NHS waiting times, breast cancer rulebook and Bluetooth headphones

Science blog New online tool could help predict prostate cancer survival The Telegraph covered a new online tool that could help estimate how likely a man is to survive his prostate cancer. It com

Friday 15th March 2019

An Inclusive, Welcoming Wisconsin? ‘Toward One Wisconsin’ Conference to Address Barriers, What’s Working, What’s Ahead – April 11-12

A statewide conference on April 11-12 in Milwaukee will seek answers to this question, bringing together policy influencers, experts in inclusive environments and groups from diverse backgrounds to examine the most persistent barriers to inclusion, highlight what is working now and what is promising on the horizon. The Toward One Wisconsin Inclusi...

Conn. High Court Ruling Clears Way For Sandy Hook Families To Sue Gun Manufacturer Over Wrongful Marketing

In the lawsuit, the Sandy Hook families seized upon the marketing for the AR-15-style Bushmaster used in the 2012 attack, which invoked the violence of combat and used slogans like “Consider your man card reissued.” Lawyers for the families argued that those messages reflected a deliberate effort to appeal to troubled young men like Adam Lanza. The court found that sweeping federal protections...

Opioid Prescriptions Dropped for New Users From 2012 to 2017

FRIDAY, March 15, 2019 -- Many providers stopped initiating opioid therapy from July 2012 to December 2017, according to a report published in the March 14 issue of the New England Journal of Medicine. Wenjia Zhu, Ph.D., from Harvard Medical School...

Pivotal Trial Results for Glaukos’ iStent inject® Published in Leading Ophthalmic Journal

Study Published in Ophthalmology Demonstrates Significant, Sustained Clinical Benefit and Confirms Favorable Safety Profile for Next-Generation Device Approved by FDA in June 2018 Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and s...

Wednesday 13th March 2019

Cutbacks by some doctors halved new opioid prescriptions over 5 years

(Reuters Health) - The rate of first-time opioid prescriptions declined 54 percent between 2012 and 2017 in the U.S., largely because many doctors stopped prescribing the painkillers, according to a study of more than 86 million people covered by pri...

Glaukos Technologies Featured in Numerous Presentations at 2019 American Glaucoma Society Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, announced today that its products will be featured in various presentations at the American Glaucoma ...

Rewriting the breast cancer rulebook 

Science blog In 2012, our scientists redefined breast cancer. By analysing samples from nearly 2000 tumours they found that breast cancer was not one, but 10 different diseases, as we explained in our blog post. Led by Professor Carlos Caldas, ba

Deuterium Depletion is a Disruptive Innovation in the Pharma Industry - HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases

BUDAPEST, Hungary, March 13, 2019 / B3C newswire / -- Science ignored the presence of the heavy hydrogen, deuterium (D) in living organisms for 60 years since its discovery by Harold C. Urey in the early 30’s, despite the fact, that the concentration of deuterium is 6-time higher than that of the normal blood calcium level. Recently, the pharma industry recognized the potential in the strategic...

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Lymphoma, Non-Hodgkin,Hodgkin Disease, Date of authorisation: 25/10/2012, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Lymphoma, Non-Hodgkin,Hodgkin Disease, Date of authorisation: 25/10/2012, Revision: 24, Status: Authorised

NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting

BASEL, Switzerland, March 13, 2019 / B3C newswire / -- NBE-Therapeutics AG, a biopharmaceutical company developing next-generation, immune-stimulatory antibody-drug conjugates (iADCs) for improved cancer therapy, today announces that it will present a late-breaking abstract at the Annual Meeting of the American Association for Cancer Research (AACR) to be held from March 29 - April 3, 2019 in Atl...

AirXpanders Provides Update on Strategic Purchasing Agreements with Several Academic Medical Centers

SAN JOSE, California, March 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today provided an update on strategic agreements with prestigious academic medical centers and group purchasing organizations across the United States. "Th...

Tuesday 12th March 2019

International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery

At 5 Years Postoperative, Mean IOP Decreased 38% to 14.7 mmHg and Topical Ocular Hypotensive Medication Use Declined 75% while Safety Profile Remained Favorable Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceut...

InkSpace Imaging Appoints Peter Fischer as CEO

InkSpace Imaging is pleased to announce that the Board of Directors has appointed Dr. Peter Fischer as Chief Executive Officer, effective March 26. After closing its first round of private funding in February of this year, InkSpace Imaging is looking forward to continued growth under the leadership of Dr. Fischer. “We are delighted to bring Dr. ...

Rx Drug Abuse & Heroin Summit Announces Top Federal Health Officials Joining the Lineup for the 8th Annual Conference

Nation’s largest meeting addressing the opioid epidemic brings lawmakers, physicians, law enforcement, clinicians, and advocates together for four days focused on solutions MALVERN, Pa. (PRWEB) March 12, 2019 As part of continued efforts to address the opioid epidemic, the largest and most complex public health crisis facing the US, the Rx Drug Abuse & Heroin Summit today announced the firs...

Heart Disease Affecting More Young Women; InfoBionic Points to Earlier Diagnosis

Women between the ages of 35 and 55 accounted for a 32 percent greater percentage of all heart attacks among women – even as the incidence of heart attacks among similarly aged men remained nearly constant. Doctors are turning to new technologies and early intervention to reverse the trend. LOWELL, Mass. (PRWEB) March 12, 2019 A recent study, published in the cardiology journal Circulation, fo...

How Much Difference Will Eli Lilly’s Half-Price Insulin Make?

Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.

Monday 11th March 2019

The science of sleep

Getting enough sleep is vital to supporting our immune system in fighting off pathogens, but scientists still don’t know exactly how sleep affects certain immune functions. Now, researchers from the Universities of Tübingen and Lübeck have discovered a new mechanism by which sleep supports the immune system, showing that the function of T cells — the white blood cells that are responsible fo...

Quick Search


News Quicklinks